EGFR and breast cancer: GEPIA2 database analysis revealed significant downregulation of PIK3R1, AKR1C3, and EGFR mRNAs in breast cancer tissue, with ESR1 upregulation, pointing to a complex interplay in tumorigenesis and treatment response [53].